Filter
1430
Text search:
pharmaceutical
products
Featured
Recommendations
133
New Publications
384
Language
Document type
No document type
670
Studies & Reports
297
Guidelines
237
Manuals
84
Strategic & Response Plan
69
Fact sheets
30
Training Material
23
Situation Updates
10
Resource Platforms
6
Brochures
2
Infographics
1
Online Courses
1
Countries / Regions
Kenya
65
Global
57
Ethiopia
46
India
46
Nigeria
32
South Africa
30
Western and Central Europe
30
Sierra Leone
27
Uganda
26
Ghana
25
Liberia
24
Rwanda
24
Tanzania
22
Namibia
21
Ukraine
19
Zambia
18
Malawi
17
Africa
17
Philippines
15
Nepal
15
Zimbabwe
14
Bangladesh
14
Indonesia
13
Latin America and the Carribbean
13
Eastern Europe
13
Myanmar / Burma
11
Eswatini/ Swaziland
9
Lesotho
9
West and Central Africa
8
Syria
7
Botswana
7
Burkina Faso
6
Cambodia
6
South–East Asia Region
6
Eastern Europe and Central Asia
6
Asia
6
Senegal
5
Congo, Democratic Republic of
5
East and Southern Africa
5
Cameroon
4
Haiti
4
Thailand
4
Benin
4
Venezuela
4
Guinea
3
South Sudan
3
Jordan
3
China
3
Mozambique
3
Sudan
3
North Macedonia
3
Russia
3
North America
3
Mali
2
USA
2
Pakistan
2
Germany
2
Egypt
2
Papua New Guinea
2
Central African Republic
2
Brazil
2
Serbia
2
Madagascar
2
Middle East and North Africa
2
Western Pacific Region
2
Fiji
2
Albania
2
Laos
2
Moldova
2
Kyrgyzstan
2
Georgia
2
Vietnam
2
Jamaica
2
United Kingdom
2
Saudi Arabia
1
Niger
1
Somalia
1
Iraq
1
Afghanistan
1
Lebanon
1
Malaysia
1
Peru
1
Ecuador
1
Libya
1
Armenia
1
Mongolia
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Gabon
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
580
Clinical Guidelines
101
Key Resources
68
Public Health
65
Women & Child Health
40
Pharmacy & Technologies
37
Capacity Building
10
Annual Report MEDBOX
1
Toolboxes
Pharmacy
178
AMR
163
COVID-19
90
HIV
64
TB
64
Mental Health
56
Planetary Health
39
NTDs
36
Rapid Response
28
Global Health Education
27
Caregiver
26
NCDs
26
Conflict
24
Malaria
23
Health Financing Toolbox
21
Ebola & Marburg
20
2.0 Rapid Response
15
Disability
9
Refugee
7
Specific Hazards
7
Polio
6
Natural Hazards
6
Zika
3
Cholera
1
This curricula guide builds on several existing products of WHO and partners, aimed at supporting countries in their effort to address the first objective of the GAP-AMR (to improve awareness and understanding of AMR). It is targeted specifically at
...
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease b
...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood f
...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan
...
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o
...
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Medicines and Health Products Price and Availa
...
This Medical Product Alert relates to the recent circulation of two confirmed falsified versions of Quinine
Sulphate circulating in Cameroon and the Democratic Republic of the Congo, containing zero active
pharmaceutical ingredient
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the vi
...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provi
...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the f ...
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the f ...
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used
...
WHO Regional Publications, Western Pacific Series No. 23
Reports the findings and recommendations of a working group convened to prepare guidelines for the use of herbal medicines in Western Pacific countries. Addressed to national health authorities, the report responds to the widespread use o ...
Reports the findings and recommendations of a working group convened to prepare guidelines for the use of herbal medicines in Western Pacific countries. Addressed to national health authorities, the report responds to the widespread use o ...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms:
...
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the Use of Veterinary Drugs CAC/RCP 38-1993. Its obj
...
Maintaining proper storage conditions for health commodities is vital to ensuring their quality. Product expiration dates are based on ideal storage conditions and protecting product quality until their expiration date is important for serving customers and conserving resources. Guidelines for the S
...
These guidelines have been developed for scientific purpose with the main aim to guide the regulatory authority for evaluating probiotic products in our country.
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infec
...
